Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ Precision Neuroscience Corporation has raised $12 million in a Series A Financing led by Steadview Capital and B Capital Group s Ascent Team. Precision Neuroscience is developing a platform for next generation brain-computer interface technology, with a focus on minimally invasive device delivery. Neural interfaces represent a frontier in medicine, biology, and computer science that will be as transformative for society as the genomics revolution, commented Precision Neuroscience co-founder and Chief Science Officer Benjamin Rapoport, a neurosurgeon who holds a PhD in electrical engineering from MIT and has been developing brain-computer interfaces for more than 15 years. We hope to unlock the potential of brain-computer interfaces with our ground breaking minimally invasive approach.